Member Info for graking

On the completely unscientific view that tomorrow morning will see a return to todays opening price, I have placed a fixed bid at 166p to expire tomorrow night. Hope I am wrong as have a good number already but its a gamble in the hope the price will next week hit a modest 175p. Otherwise I do not expect too much from this investment till the preliminary good news (or not) arrives in late February or early March. My instincts (often wrong) tell me that a favourable early outcome even though not scientifically based, will lift this share massively.

Still nicely blue without an associated price rise which sometimes suggests a big buyer with clout is at work. Or could be some large sells being held back. Who knows, but tomorrow should be clearer

Considering the amount of blues, somethings afoot. Unless there are sellers we havn.t seen yet.

Barrick Gold ?

Sounds more like an darts shout than a medically relevant target. Not really worth the paper it was written on. Hospital based trials are the only truly acceptable course so lets wait for that shout.

will push for therapeutics that shorten and therefore minimise the cost of a hospital stay. AND it would also herald a new approach from Biden. Exactly what he needs to break away from the Trump reliance solely on vaccines from Trumps mates in the big Pharma industry

BUT it could be a message from the gods - an RNS today telling us a large holder has gone over a percentage threshold ??

No way will the current vaccine work on variants. The annual flu jab evidences that and we don't know if that has ever worked. Treatment is the answer for those not having good immune systems as is natural herd immunity as happened following Spanish Flu.

Phase 3 may well be completed in Summer but if the early results show high success levels, Governments will immediately place massive advance orders to ensure stocks are immediately available following approvals. Thats why I believe (if showing high success rates) this will result in an RNS by end February. Clinigen (see Sept RNS) work closely with pharma companies to, inter alia, ensure timely entry of unlicensed medicines into the right markets. They are geared to monitor and publicise early outcomes via their monitoring software. If for no other reason, they need to quickly know the results of early stage trials simply to encourage hospital groups to join in.

The situation brings out the Darwinists. In the longer term, only those with the best genes will survive. OR we rey and vaccinate the world every year with a vaccine that is untested on variants around the corner. Not the way to run anything as more of us then die from other problems aka lack of NHS care. Rose tinted glasses are exactly what they say on the spec case.

This will ramp far quicker than in the UK. NHS costs are important in the UK but insurance companies in the US will be euphoric if the latest trials stand up. If it saves one day in a private hospital, it pays for itself and if it saves 5 days it pays for itself several fold. Given no supply issues it will be trialled very quickly in private hospitals including those in the UK. I suspect that if successful, the States will lead the charge, weeks ahead of the UK.

Same ward to stop awkward questions to medical staff

https://todayheadline.co/mass-trial-of-repurposed-ms-drug-for-covid-begins-at-hospital-in-hull/

From an English standpoint and not the world, probably take a month for the NHS via its 191 English Clinical Care Groups to agree protocols and for hospitals to then order and receive receive sufficient trial supplies. In that time the producers of the trial packs would gear up to this phased trial period but would require firm orders. Not an overnight thing. So in that first month after protocols established and orders placed, individual hospitals would receive say hundreds of first batch training packs for staff training on first (suitable) volunteers and set up report back arrangements for the longer term. Would not expect fully analysed and independently checked results until end March. Be nice if the various national Governments would, as with vaccines, order stocks in anticipation but suspect they will respond to what the CCG's say first and any early findings from the initial trials. A slow but sensible start admittedly and as vaccines have caught the national imagination and all eyes are on them. Politically it has to be one thing at a time but who really knows, what if if hospitals start seeing a very fast bed turnaround at the end of the first, albeit preparatory full month, vaccines or not.

Hopefully as its a Southampton based company, todays BBC TV - South Today will be reporting it

WHAT KEPT THEM ! - and the US included

I remain totally unconvinced that Vaccination is the answer. Imagine trying to vaccinate everybody once a year across Britain, let alone Europe and the rest of the world. Surely, like the Spanish Flu, we have to ignore the clever medicine men and scared politicians and refer back to say the Spanish Flu when it disappeared after about 2 years . As no one heard of it at the time, no one really knows how devastating it was. No records and how many internationally linked Statisticians were there in 1918 ? Probably what few there were died at Verdunne. In conclusion, surely as in 1919, let the population catch it, let those with weak immune systems be looked after at reasonable cost and let the rest build up an immunity to last a lifetime and pass there genes on to at least one more generation. Darwin was dead right about the origin of species. OR WE CAN MOLLY CODDLE AND COTTON WOOL THE WHOLE WORLD WITH A VACCINE WHICH EACH YEAR WILL BE ABOUT 12 MONTHS OUT OF DATE. aka THE WINTER FLU JAB and probably be locked down one way or another forever.

Brilliant piece of reporting. The promised RNS once first dose of Trial 3 is provided will be a boon for the share price. Another 400% ?

I believe all miners keep many finds close to their chests to publicise on a progressive basis. That way the price keeps rising at an acceptable rate each year. No large investor (including directors) want a crippling one off capital gains tax. were they to sell a chunk in any one year.

The Ocado rise today could well reflect today's news that ASOS are to build a £20m UK warehouse. I suspect that most large High Street retailers will be considering doing the same simply to catch up with lost shop sales. Will be a major hurdle this next 2 years for Ocado software to keep up with the likely demand for mega automated warehouses as they only have so many skilled staff and hours available